Biden T J, Altin J G, Karjalainen A, Bygrave F L
Department of Biochemistry, Faculty of Science, Australian National University, Canberra, ACT.
Biochem J. 1988 Dec 15;256(3):697-701. doi: 10.1042/bj2560697.
A cytosolic fraction derived from rat hepatocytes was used to investigate the regulation of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] kinase, the enzyme which converts Ins(1,4,5)P3 to inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4]. The activity was doubled by raising the free Ca2+ concentration of the assay medium from 0.1 microM to 1.0 microM. A 5 min preincubation of the hepatocytes with 100 microM-dibutyryl cyclic AMP (db.cAMP) plus 100 nM-tetradecanoylphorbol acetate (TPA) resulted in a 40% increase in Ins(1,4,5)P3 kinase activity when subsequently assayed at 0.1 microM-Ca2+. This effect was smaller at [Ca2+] greater than 0.5 microM, and absent at 1.0 microM-Ca2+. Similar results were obtained after preincubation with 100 microM-db.cAMP plus 300 nM-vasopressin (20% increase at 0.1 microM-Ca2+; no effect at 1.0 microM-Ca2+). Preincubation with vasopressin, db.cAMP or TPA alone did not alter Ins(1,4,5)P3 kinase activity. It is proposed that these results, together with recent evidence implicating Ins(1,3,4,5)P4 in the control of Ca2+ influx, could be relevant to earlier findings that hepatic Ca2+ uptake is synergistically stimulated by cyclic AMP analogues and vasopressin.
从大鼠肝细胞中提取的胞质部分用于研究肌醇1,4,5 - 三磷酸[Ins(1,4,5)P3]激酶的调节作用,该酶可将Ins(1,4,5)P3转化为肌醇1,3,4,5 - 四磷酸[Ins(1,3,4,5)P4]。将测定介质中的游离Ca2 +浓度从0.1微摩尔/升提高到1.0微摩尔/升,可使该酶活性增加一倍。肝细胞先用100微摩尔/升二丁酰环磷酸腺苷(db.cAMP)加100纳摩尔/升十四酰佛波醇乙酯(TPA)预孵育5分钟,随后在0.1微摩尔/升Ca2 +浓度下测定时,Ins(1,4,5)P3激酶活性增加40%。在Ca2 +浓度大于0.5微摩尔/升时,这种效应较小,而在1.0微摩尔/升Ca2 +浓度时则不存在。用100微摩尔/升db.cAMP加300纳摩尔/升血管加压素预孵育后也得到类似结果(在0.1微摩尔/升Ca2 +浓度下增加20%;在1.0微摩尔/升Ca2 +浓度下无作用)。单独用血管加压素、db.cAMP或TPA预孵育不会改变Ins(1,4,5)P3激酶活性。有人提出,这些结果连同最近有关Ins(1,3,4,5)P4参与控制Ca2 +内流的证据,可能与早期发现的环磷酸腺苷类似物和血管加压素协同刺激肝脏Ca2 +摄取有关。